Loading...
Chemical structure of Mivebresib

GC19248

Mivebresib

Also known as N-[4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl]ethanesulfonamide

Mivebresib is a potent and orally available bromodomain and extraterminal domain (BET) bromodomain inhibitor

ChemicalCAS1445993-26-9MW459.47FormulaC22H19F2N3O4S
CAS number
1445993-26-9
Molecular weight
459.47
Formula
C22H19F2N3O4S
Solubility
DMSO ： 100 mg/mL (217·64 mM)
InChIKey
RDONXGFGWSSFMY-UHFFFAOYSA-N
Catalogue number
GC19248
Brand
GLPBIO
Computed properties PubChem CID 71600087 · XLogP 2.9 · TPSA 99.9 Ų · H-bond donors 2
XLogP
2.9
TPSA
99.9 Ų
H-bond donors
2
H-bond acceptors
7
Rotatable bonds
6
Heavy atoms
32

SMILES CCS(=O)(=O)NC1=CC(=C(C=C1)OC2=C(C=C(C=C2)F)F)C3=CN(C(=O)C4=C3C=CN4)C

Computed descriptors from PubChem (CID 71600087), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.